Mark PB - Search Results

1

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.

Cholesterol Treatment Trialists' (CTT) Collaboration; Herrington WG, Emberson J, Mihaylova B, Blackwell L, Reith C, Solbu MD, Mark PB, Fellström B, Jardine AG, Wanner C, Holdaas H, Fulcher J, Haynes R, Landray MJ, Keech A, Simes J, Collins R, Baigent C. Cholesterol Treatment Trialists' (CTT) Collaboration, et al. Among authors: mark pb. Lancet Diabetes Endocrinol. 2016 Oct;4(10):829-39. doi: 10.1016/S2213-8587(16)30156-5. Epub 2016 Jul 29. Lancet Diabetes Endocrinol. 2016. PMID: 27477773 Free article.

2

Determinants of hypertension and left ventricular function in end stage renal failure: a pilot study using cardiovascular magnetic resonance imaging.

Stewart GA, Mark PB, Johnston N, Foster JE, Cowan M, Rodger RS, Dargie HJ, Jardine AG. Stewart GA, et al. Among authors: mark pb. Clin Physiol Funct Imaging. 2004 Nov;24(6):387-93. doi: 10.1111/j.1475-097X.2004.00583.x. Clin Physiol Funct Imaging. 2004. PMID: 15522049 Clinical Trial.

3

Hypertension, antihypertensive agents and outcomes following renal transplantation.

Tutone VK, Mark PB, Stewart GA, Tan CC, Rodger RS, Geddes CC, Jardine AG. Tutone VK, et al. Among authors: mark pb. Clin Transplant. 2005 Apr;19(2):181-92. doi: 10.1111/j.1399-0012.2004.00315.x. Clin Transplant. 2005. PMID: 15740553

4

Endothelial dysfunction in renal transplant recipients.

Mark PB, Murphy K, Mohammed AS, Morris ST, Jardine AG. Mark PB, et al. Transplant Proc. 2005 Nov;37(9):3805-7. doi: 10.1016/j.transproceed.2005.09.116. Transplant Proc. 2005. PMID: 16386545 Review.

5

Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation.

Hillyard DZ, Nutt CD, Thomson J, McDonald KJ, Wan RK, Cameron AJ, Mark PB, Jardine AG. Hillyard DZ, et al. Among authors: mark pb. Atherosclerosis. 2007 Apr;191(2):319-25. doi: 10.1016/j.atherosclerosis.2006.05.037. Epub 2006 Jun 30. Atherosclerosis. 2007. PMID: 16814295

6

Cardiovascular magnetic resonance imaging has much to offer in the assessment of renal transplant recipients.

Mark PB, Jardine AG. Mark PB, et al. Am J Transplant. 2006 Aug;6(8):1975-6. doi: 10.1111/j.1600-6143.2006.01376.x. Am J Transplant. 2006. PMID: 16889553 Free article. No abstract available.

7

Cardiovascular disease management in renal transplant recipients: more or less treatment?

Wan RK, Mark PB, Jardine AG. Wan RK, et al. Among authors: mark pb. Transplantation. 2006 Sep 27;82(6):737-8. doi: 10.1097/01.tp.0000235431.71677.e3. Transplantation. 2006. PMID: 17006317 No abstract available.

8

Vascular function in patients with end-stage renal disease and/or coronary artery disease: a cardiac magnetic resonance imaging study.

Zimmerli LU, Mark PB, Steedman T, Foster JE, Berg GA, Dargie HJ, Jardine AG, Delles C, Dominiczak AF. Zimmerli LU, et al. Among authors: mark pb. Kidney Int. 2007 Jan;71(1):68-73. doi: 10.1038/sj.ki.5002024. Epub 2006 Nov 15. Kidney Int. 2007. PMID: 17136027 Free article.

9

Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure.

Mark PB, Petrie CJ, Jardine AG. Mark PB, et al. Semin Dial. 2007 Jan-Feb;20(1):40-9. doi: 10.1111/j.1525-139X.2007.00240.x. Semin Dial. 2007. PMID: 17244121 Review.

10

Are we overestimating left ventricular abnormalities in end-stage renal disease?

Mark PB, Patel RK, Jardine AG. Mark PB, et al. Nephrol Dial Transplant. 2007 Jul;22(7):1815-9. doi: 10.1093/ndt/gfm224. Epub 2007 Apr 16. Nephrol Dial Transplant. 2007. PMID: 17438003 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

271 results

Search Page